4Ohigashi H,Ishikawa O,Imaoka S.A new method of intra-arterial regional chemotherapy with more selective drug deliver for locally advanced pancreatic cancer [J].Hepatogastroenterology,1996,43(8):338-345.
5Machmore JH,Preslan JE,George WJ.Regional chemotheraphy for inoperable pancreatic carcinoma[J].Cancer,1996,78(3 Suppl):664-673.
4[1]Lorenz M, Heinrich S, Staib-Sebler E, et al. Regional chemotherapy in the treatment of advanced pancreatic cancer -is it relevent ? Eur J Cancer, 2000,36(8):957-965
5[4]Beger HG, Gansauge F, Buchler MW,et al. Intra-arterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis. World J Surg,1999,23(9):946-949
6[5]Ozaki H , Kinoshita T, Kosuge T, et al. Long-term survival after multimodality treatment for resectable pancreatic cancer. Int J Pancreatol, 2000,27(3):217-224
7[6]Halm U, Schumann T, Schiefke I, et al. Decrease of CA19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer, 2000, 82(5): 1013-1016
8[8]Klapdor R, Muller C, Seutter R, et al. Improvement of survival by efficacy orientated sequential polychemotherapy of exocrine pancreatic cancer. Anticancer Res,2000,20(6D):5201-5207
9Dancey J, Eisenbauer FLA. Cunrrent petspectives on camptothecin in cancer treaunent[J]. Br J Cancer, 1996,74:327-338.
10Bodley A, Leroy FL, Israel M, et al. DNA topoisomerase Ⅱ-mediated interaction of doxorubicin and daunorubicin congeners with DNA[J].Cancer Res, 1989,49:5969-5978.
